All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Completed, but no date Terminated | 2014-005523-27 | Multicenter prospective randomized trial of the effect of rivaroxaban on survival and development of complications of portal hypertension in patients with cirrhosis Estudio prospectivo multicéntric... | bad-data | |
Completed, but no date | 2015-004238-85 | Ictal brain SPECT in the premotor stage of Parkinson disease SPECT Ictal de perfusión cerebral en el periodo premotor de la enfermedad de Parkinson | bad-data | |
Ongoing | 2016-000347-14 | Cell proliferation in pulmonary hypertension: mollecular imaging detection by FDG PET. Comparative study between patients and healthy subjects Proliferación celular en la hipertensión pulmonar: Det... | not-yet-due | |
Exempt | 2016-002972-29 | Pilot study on the infusion of differentiated autologous T-cells from peripheral blood, expanded and transduced with a lentivirus to express a chimeric antigen receptor with anti-CD19 specificity (A3B... | not-yet-due | |
Not reported Terminated | 2016-003451-30 | Subjects with subjective cognitive decline: 18F-Florbetaben Positrón Emission Tomography Study. Estudio de sujetos con deterioro cognitivo subjetivo: estudio con Tomografía por Emisión de Positrone... | 2019-02-28 | due-trials |
Reported results | 2016-004499-23 | Safety and tolerability of the combination of simvastatin plus rifaximin in patients with decompensated cirrhosis: a multicenter, double-blind, placebo controlled randomized clinical trial. | 2018-03-12 | due-trials |
Listed as ongoing, but also has a completion date | 2018-001698-25 | Efficacy of the combination of simvastatin plus rifaximin in patients with decompensated cirrhosis to prevent ACLF development: a multicenter, double-blind, placebo controlled randomized clinical tria... | 2022-12-01 | bad-data |
Ongoing | 2019-003038-17 | Phase 2 study of the infusion of differentiated autologous T-cells from peripheral blood, expanded and transduced with a lentivirus to express a chimeric antigen receptor with anti-CD19 specificity (A... | not-yet-due | |
Ongoing | 2020-006023-33 | Efficacy of simvastatin reducing liver fibrosis in patients with advanced fibrosis due to alcohol: a randomized, double-blind, placebo-controlled clinical trial. Eficacia de la simvastatina para r... | not-yet-due | |
Ongoing | 2021-001288-26 | Safety, tolerance and antiretroviral activity of dasatinib: a pilot clinical trial in patients with recent HIV-1 infection Seguridad, tolerancia y actividad antirretroviral de dasatinib: estudio cl... | not-yet-due | |
Ongoing | 2022-000358-26 | Safety, tolerability, and efficacy of a dose reduction strategy based on bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed HIV-infected adults. Seguridad, tolerabilidad y ... | not-yet-due | |
Ongoing | 2022-001858-33 | Randomized controlled trial comparing conventional antibiotic strategies versus regimens guided by epidemiological surveillance in infected patients with cirrhosis. Estidio controlado aleatorizado ... | not-yet-due |